These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 3151427)
41. Glucan as an adjuvant for a murine Babesia microti immunization trial. Benach JL; Habicht GS; Holbrook TW; Cook JA Infect Immun; 1982 Mar; 35(3):947-51. PubMed ID: 7068224 [TBL] [Abstract][Full Text] [Related]
42. Immunosuppression by larval cestodes of Babesia microti infections. Nichol CP; Sewell MM Ann Trop Med Parasitol; 1984 Jun; 78(3):228-33. PubMed ID: 6385886 [No Abstract] [Full Text] [Related]
43. Bovine babesiosis: Cattle protected in the field with a frozen vaccine containing Babesia bovis and Babesia bigemina cultured in vitro with a serum-free medium. Rojas-Martínez C; Rodríguez-Vivas RI; Millán JVF; Bautista-Garfias CR; Castañeda-Arriola RO; Lira-Amaya JJ; Urióstegui PV; Carrasco JJO; Martínez JAÁ Parasitol Int; 2018 Apr; 67(2):190-195. PubMed ID: 29155165 [TBL] [Abstract][Full Text] [Related]
44. Babesia microti, human babesiosis, and Borrelia burgdorferi in Connecticut. Anderson JF; Mintz ED; Gadbaw JJ; Magnarelli LA J Clin Microbiol; 1991 Dec; 29(12):2779-83. PubMed ID: 1757548 [TBL] [Abstract][Full Text] [Related]
45. Evaluation of the in vitro growth-inhibitory effect of epoxomicin on Babesia parasites. Aboulaila M; Nakamura K; Govind Y; Yokoyama N; Igarashi I Vet Parasitol; 2010 Jan; 167(1):19-27. PubMed ID: 19896277 [TBL] [Abstract][Full Text] [Related]
46. Babesia microti thioredoxin 3 is an effective antioxidant and involved in the response to antiprotozoal drugs. Huang J; Xiong K; Zhang H; Zhao Y; Cao J; Zhou Y; Gong H; Zhou J Ticks Tick Borne Dis; 2018 Mar; 9(3):645-653. PubMed ID: 29472160 [TBL] [Abstract][Full Text] [Related]
47. Phagocytic and bactericidal function of mouse macrophages to Salmonella typhimurium in schistosomiasis mansoni. Muniz-Junqueira MI; Prata A; Tosta CE Am J Trop Med Hyg; 1992 Feb; 46(2):132-6. PubMed ID: 1539746 [TBL] [Abstract][Full Text] [Related]
48. Prostaglandin-mediated suppression of delayed-type hypersensitivity to infected erythrocytes during Babesia microti infection in mice. Ruebush MJ; Steel LK; Kennedy DA Cell Immunol; 1986 Apr; 98(2):300-10. PubMed ID: 2944617 [TBL] [Abstract][Full Text] [Related]
49. Human babesiosis: Indication of a molecular mimicry between thrombospondin domains from a novel Babesia microti BmP53 protein and host platelets molecules. Mousa AA; Roche DB; Terkawi MA; Kameyama K; Kamyingkird K; Vudriko P; Salama A; Cao S; Orabi S; Khalifa H; Ahmed M; Attia M; Elkirdasy A; Nishikawa Y; Xuan X; Cornillot E PLoS One; 2017; 12(10):e0185372. PubMed ID: 29040286 [TBL] [Abstract][Full Text] [Related]
50. Antibody levels in adoptively immunized mice after infection with Babesia microti or injection with antigen fractions. Meeusen E; Lloyd S; Soulsby EJ Aust J Exp Biol Med Sci; 1985 Jun; 63 ( Pt 3)():261-72. PubMed ID: 2415100 [TBL] [Abstract][Full Text] [Related]
51. Artesunate, a potential drug for treatment of Babesia infection. Goo YK; Terkawi MA; Jia H; Aboge GO; Ooka H; Nelson B; Kim S; Sunaga F; Namikawa K; Igarashi I; Nishikawa Y; Xuan X Parasitol Int; 2010 Sep; 59(3):481-6. PubMed ID: 20541037 [TBL] [Abstract][Full Text] [Related]
52. The chemiluminescent response of macrophages in mice infected with Schistosoma mansoni. el-Nassery SM; Rashwan EA; Abu-el-Nazar SY J Egypt Soc Parasitol; 1992 Apr; 22(1):189-94. PubMed ID: 1578167 [TBL] [Abstract][Full Text] [Related]
53. Evaluation of the use of C-terminal part of the Schistosoma mansoni 200kDa tegumental protein in schistosomiasis diagnosis and vaccine formulation. Carvalho GB; Pacífico LG; Pimenta DL; Siqueira LM; Teixeira-Carvalho A; Coelho PM; Pinheiro Cda S; Fujiwara RT; Oliveira SC; Fonseca CT Exp Parasitol; 2014 Apr; 139():24-32. PubMed ID: 24560833 [TBL] [Abstract][Full Text] [Related]
54. Vaccination against babesiosis using recombinant GPI-anchored proteins. Nathaly Wieser S; Schnittger L; Florin-Christensen M; Delbecq S; Schetters T Int J Parasitol; 2019 Feb; 49(2):175-181. PubMed ID: 30684517 [TBL] [Abstract][Full Text] [Related]
55. Indirect immunofluorescence test for human Babesia microti infection: antigenic specificity. Chisholm ES; Sulzer AJ; Ruebush TK Am J Trop Med Hyg; 1986 Sep; 35(5):921-5. PubMed ID: 2429568 [TBL] [Abstract][Full Text] [Related]
56. A short term in vitro cultivation of Babesia rodhaini and Babesia microti. Shikano S; Nakada K; Hashiguchi R; Shimada T; Ono K J Vet Med Sci; 1995 Oct; 57(5):955-7. PubMed ID: 8593312 [TBL] [Abstract][Full Text] [Related]
58. Babesia: the protective effects of killed Propionibacterium acnes on the infections of two rodent Babesia parasites in mice. Iseki H; Takabatake N; Ota N; Ishigame T; Yokoyama N; Igarashi I Exp Parasitol; 2008 Apr; 118(4):543-8. PubMed ID: 18164706 [TBL] [Abstract][Full Text] [Related]
59. Reduced dietary protein content suppresses infection with Babesia microti. Tetzlaff CL; Carlomagno MA; McMurray DN Med Microbiol Immunol; 1988; 177(6):305-15. PubMed ID: 3216813 [TBL] [Abstract][Full Text] [Related]
60. Case report of the patient source of the Babesia microti R1 reference strain and implications for travelers. Stahl P; Poinsignon Y; Pouedras P; Ciubotaru V; Berry L; Emu B; Krause PJ; Ben Mamoun C; Cornillot E J Travel Med; 2018 Jan; 25(1):. PubMed ID: 29394381 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]